Will a nasal corticosteroid improve control for patients with step 3 or higher persistent asthma?

Affiliations

¹ Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: p-greenberger@northwestern.edu.

Editorial

Paul A Greenberger. J Allergy Clin Immunol. 2015 Mar.

. 2015 Mar;135(3):710-1.

doi: 10.1016/j.jaci.2014.12.1910. Epub 2015 Jan 25.

¹ Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: p-greenberger@northwestern.edu.

No abstract available

Keywords: United; asthma; control; corticosteroid; nasal; rhinosinusitis; unified.

Comment on

Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.
American Lung Association–Asthma Clinical Research Centers' Writing Committee; Dixon AE, Castro M, Cohen RI, Gerald LB, Holbrook JT, Irvin CG, Mohapatra S, Peters SP, Rayapudi S, Sugar EA, Wise RA. American Lung Association–Asthma Clinical Research Centers' Writing Committee, et al. J Allergy Clin Immunol. 2015 Mar;135(3):701-9.e5. doi: 10.1016/j.jaci.2014.06.038. Epub 2014 Aug 28. J Allergy Clin Immunol. 2015. PMID: 25174863 Free PMC article. Clinical Trial.